Lifecore Biomedical, Inc. LFCR Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Lifecore Biomedical, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s cash ratio?
- Lifecore Biomedical, Inc. (LFCR) reported cash ratio of 1× in Q1 2026.
- How has Lifecore Biomedical, Inc.'s cash ratio changed year-over-year?
- Lifecore Biomedical, Inc.'s cash ratio increased by 270.4% year-over-year, from 0.3× to 1×.
- What is the long-term trend for Lifecore Biomedical, Inc.'s cash ratio?
- Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s cash ratio has grown at a 166.8% compound annual growth rate (CAGR), from 0× to 1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.